PRP Injections: A Promising Solution for Osteoarthritis

Find out how PRP injections for osteoarthritis can be a game-changer for those suffering from chronic joint issues.

Abstract

In this educational post, I will guide you through the latest evidence-based findings on injectable treatments for common musculoskeletal conditions, specifically osteoarthritis (OA) and tendinopathy. As a clinician dedicated to integrative and functional medicine, my focus is on harnessing the body’s innate healing capabilities, supported by the latest research. We will embark on a journey starting with a common clinical scenario—an acute knee OA flare-up—to explore the pros and cons of various injectables. I will present the most current research from leading investigators, moving from traditional options such as corticosteroids to contemporary treatments such as intra-articular NSAIDs (Ketorolac), hyaluronic acid (HA), and platelet-rich plasma (PRP). We will dissect the nuances of PRP, examining the critical role of dosage in achieving successful outcomes. My goal is to break down the physiological mechanisms, clinical efficacy, and potential risks of each option, empowering you to make informed decisions. Furthermore, I will explain how an integrative chiropractic framework, which emphasizes structural integrity, biomechanics, and holistic wellness, complements these advanced medical interventions to optimize patient outcomes and promote long-term joint health.

A Common Clinical Challenge: The Acute Knee Osteoarthritis Flare

Let’s begin by considering a case that I frequently encounter in my practice. A 60-year-old female patient presents with an acute flare of right knee pain. I first saw her two years ago for mild osteoarthritis, which responded beautifully to physical therapy and weight loss. She remains active, but this current flare started after a period of increased walking. There was no specific trauma, but she reports mild swelling, and the pain is most pronounced when using stairs. To add a layer of urgency, her son’s wedding is next weekend, and she is requesting an injection to improve her pain and mobility for the event.

On examination, she displays a mildly antalgic gait (walking to avoid pain), has tenderness along the medial joint line, and has a small effusion (fluid buildup). Her radiographs confirm tricompartmental OA with a Kellgren-Lawrence (K/L) grade of 2, which is considered mild to moderate.

So, we have a patient with an acute OA flare, no history of prior injections in that knee, and a significant life event just days away. What is the best course of action? Many practitioners would immediately default to an intra-articular corticosteroid injection. But is that the right answer? Let’s delve into the evidence together.

The Case For and Against Corticosteroids in Osteoarthritis

Why Steroids Offer Rapid Relief

The primary reason corticosteroids are a go-to for acute flares is their potent anti-inflammatory effect on the synovium. The synovium is the soft tissue lining our joints, and when it becomes inflamed (synovitis), it is a key driver of pain and effusion.

Here’s how steroids work on a cellular level:

• They suppress the infiltration of leukocytes (white blood cells) into the joint space.
• They decrease the activity of local immune cells within the synovium.
• They downregulate the expression of genes involved in the inflammatory cascade.

This powerful anti-inflammatory action leads to a rapid decrease in synovial membrane inflammation and fluid, with results often felt within three to seven days. For our patient with the upcoming wedding, this rapid pain relief is precisely the goal. While oral medications like NSAIDs or steroids could be an option, they come with significant systemic risks that a localized injection can help avoid.

The Hidden Risks: Chondrotoxicity and Long-Term Damage

Despite the short-term benefits, we must be critical and ask: at what cost? Steroids are not benign, and a growing body of evidence highlights their potential for harm. A 2024 systematic review and meta-analysis confirmed that, while intra-articular corticosteroids offer superior pain relief and functional improvement compared to placebo, this benefit loses clinical relevance after just 6 weeks (Saltychev et al., 2024).

The risks extend beyond short-lived efficacy:

• Systemic Effects: Steroids can elevate blood glucose, a significant concern for individuals with uncontrolled diabetes. They can also negatively impact bone mineral density, especially in postmenopausal women and men over 50. A single injection can even cause temporary adrenal suppression.
• Surgical Implications: It is generally recommended to wait at least three months after a steroid injection before undergoing joint replacement surgery due to an increased risk of infection.
• Cartilage Damage (Chondrotoxicity): This is perhaps the most concerning risk. Preclinical studies have robustly demonstrated that steroids have dose-dependent deleterious effects on cartilage morphology, histology, and viability. The higher the dose, the greater the damage.

A landmark clinical trial published in JAMA underscores this danger. The two-year, randomized, placebo-controlled trial compared triamcinolone (a common steroid) injections every 12 weeks to saline injections for patients with knee OA. The results were startling: while there was no significant difference in pain relief between the groups, the patients receiving repeated steroid injections experienced significantly greater cartilage volume loss over the two years (McAlindon et al., 2017).

Another large-scale retrospective review found that patients who received even a single steroid injection (for various conditions, not just OA) had a twofold greater risk of needing a knee replacement at five years compared to those who didn’t. This risk increased with each subsequent injection (Kompel et al., 2019). These findings have led to a call within the medical community to find safer alternatives.

A Steroid-Sparing Alternative: Intra-Articular Ketorolac (NSAID)

If our goal is rapid relief without the associated cartilage damage, what can we offer? An increasingly studied and effective alternative is an intra-articular injection of Ketorolac, a non-steroidal anti-inflammatory drug (NSAID).

How Ketorolac Works in the Joint

Ketorolac provides targeted anti-inflammatory and analgesic effects through a different mechanism than steroids.

• As a COX-1 and COX-2 inhibitor, it blocks the production of prostaglandins, which are key molecules in promoting inflammation and sensitizing pain receptors (nociceptors).
• When delivered directly into the joint, it achieves a high concentration in the synovial fluid with minimal systemic exposure, reducing the risks associated with oral NSAIDs.
• Crucially, unlike steroids, Ketorolac does not have the same immunosuppressive effects or gene expression changes. Preclinical models have not shown the deleterious structural effects on cartilage that we see with corticosteroids.

The onset of action is similar to steroids—within a few days—and its efficacy can last for several months. A 2022 systematic review and meta-analysis of studies on Ketorolac for musculoskeletal conditions, including hip and knee OA, found pain and functional improvements similar to corticosteroids from one week up to three months, with minimal adverse events (Saltzman et al., 2022).

In my own clinical observations, I have seen patients with hip OA experience statistically significant improvements in pain with Ketorolac compared to steroids. While the duration of effect was slightly longer in the steroid group, the onset of relief was significantly faster with Ketorolac (approximately three days versus four days for steroids).

Ketorolac serves as an excellent steroid-sparing option. However, it should be used with caution in individuals with contraindications to NSAIDs, such as a history of ulcers, cardiac or kidney disease, or those on anticoagulants. I adhere to a standard 30 mg dose for joint injections and am always cautious, ensuring patients have no history of chronic kidney disease or other contraindications.

Shifting Focus to Long-Term Joint Health: Viscosupplementation with Hyaluronic Acid (HA)

What if the patient’s goal isn’t just immediate relief from an acute flare but rather longer-term benefit and the minimization of structural risk? This is where we shift our thinking from simply putting out the inflammatory fire to addressing the joint’s underlying health. For this, we can consider hyaluronic acid (HA), also known as viscosupplementation.

Restoring the Joint’s Natural Lubricant

The core concept behind HA injections is to augment the natural viscoelastic properties of the synovial fluid. In an osteoarthritic joint, the body’s endogenous HA is depleted and degraded, reducing the synovial fluid’s viscosity and lubricating capacity. Supplementing it aims to:

• Improve joint lubrication and shock absorption.
• Modulate pain signals (nociception) and inflammation.
• Bind to receptors like CD44 on joint cells, which helps decrease inflammatory signaling (e.g., MMPs and IL-1β).
• Promote the synthesis of proteoglycans and glycosaminoglycans—the building blocks of cartilage.
• Potentially exert chondroprotective (cartilage-protecting) effects.

Clinical evidence shows that HA leads to a small but significant reduction in knee OA pain compared to placebo. The effect typically peaks around two months and can last for six months or more (Phillips et al., 2022). Interestingly, basic science suggests that high-molecular-weight HA is more effective than low-molecular-weight HA, as it has a greater chondroprotective effect and more effectively stimulates the body’s own HA production.

A large-scale study also found that patients treated with HA had a higher rate of total knee arthroplasty (TKA)-free survival at one and two years compared to those who were not. Furthermore, the median OA-related costs before surgery were significantly lower in the HA-treated group (Altman et al., 2016). Despite this, medical guidelines remain divided, and many insurance companies no longer cover the treatment, citing limited evidence of a large clinical benefit.

The Regenerative Potential: Platelet-Rich Plasma (PRP)

While HA can help the joint environment, it is not necessarily a disease-modifying agent. The ultimate goal is to find an injection that can both alleviate pain and positively modify the disease process. This brings us to the exciting field of orthobiologics, specifically Platelet-Rich Plasma (PRP).

Harnessing the Body’s Own Healing Factors

PRP is a concentration of platelets derived from the patient’s own blood. These platelets are rich in growth factors and signaling molecules that orchestrate a powerful healing response. When injected into an arthritic joint, they can:

• Modulate Inflammation: It modulates inflammatory pathways such as NF-kappa B and shifts macrophages from a pro-inflammatory (M1) to an anti-inflammatory, regenerative (M2) state.
• Stimulate Cartilage Cells: Growth factors stimulate chondrocytes to produce new cartilage matrix.
• Tissue Repair and Angiogenesis: Growth factors like VEGF, PDGF, and TGF-beta promote the formation of new blood vessels, enhancing blood supply and tissue repair.
• Delay Surgery: A 2023 study showed PRP can significantly delay the need for total knee arthroplasty (TKA) by up to seven years in patients with mild to moderate OA.

Unpacking the PRP Puzzle: Why Does is Key

While the potential of PRP is exciting, it’s crucial to understand that not all PRP is created equal. I’ve seen many patients confused by conflicting reports, with some studies showing remarkable success while others found it ineffective. We now realize the answer often lies in one critical factor: dose.

For instance, an earlier JAMA study used a low total dose of about 1.6 billion platelets, which we now understand is likely insufficient. To achieve chondroprotective effects, research points to a need for a much higher concentration, delivering around 1.5 to 2 million platelets per microliter.

A meta-regression analysis of 42 knee OA studies stratified them by total platelet dose delivered:

• Less than 5 billion platelets
• 5 to 10 billion platelets
• Greater than 10 billion platelets

The results were unequivocal. At both the six-month and 12-month marks, the high-dose group (greater than 10 billion platelets) significantly outperformed the control groups in improving pain and function, demonstrating a clear dose-response relationship. This is why, in my clinical practice, understanding the specifics of the PRP system is non-negotiable to ensure my patients receive a therapeutic, evidence-based treatment.

PRP vs. Hyaluronic Acid (HA): Making the Right Choice

A recent meta-analysis published in late 2025 confirmed what many of us have observed clinically: PRP consistently outperforms HA in improving both pain and function for knee OA, with improvements meeting the threshold for Minimally Clinically Important Difference (MCID) (Belk et al., 2023).

This leads to an intriguing question: what if we combine them? A compelling 2021 study found that in the group receiving both PRP and HA, there was a greater decrease in inflammatory markers such as IL-1β, TNF-α, and MMP-3. Clinically, the combination group showed continued improvement through 2 years, whereas the benefits of each therapy alone began to decline. From my clinical experience, this is a powerful option, particularly when a patient’s insurance covers the cost of HA, allowing us to leverage that benefit and add the regenerative capacity of PRP.

Shifting Gears: A Modern Approach to Treating Tendinopathy

Let’s now turn our attention from joints to tendons. Tendinopathy is not simply inflammation (tendinitis), but rather a degenerative condition characterized by disorganized collagen, cellular changes, and a failed healing response. I often see this in patients with lateral epicondylopathy (“tennis elbow” or, increasingly, “pickleball elbow”), rotator cuff issues, or plantar fasciitis.

Why We Must Avoid Corticosteroids for Tendons

For decades, the go-to injection for tendon pain was a corticosteroid. We now know this is often detrimental. I strongly advise against using steroids around tendons, a stance that is becoming the standard of care.

Basic science research has shown that when a tendon is exposed to corticosteroids, it leads to:

• Decreased collagen synthesis and organization.
• Toxicity to tendon cells (tenocytes).
• An increased risk of tendon necrosis and rupture.
• Changes in the tendon’s mechanical properties weaken it.

These negative effects can occur as early as 24 hours after a single injection. Clinically, while steroids might provide short-term pain relief, they fail in the long term, and the risk of recurrence is significantly higher.

PRP: The Gold Standard for Healing Tendons

To truly heal a degenerative tendon, we need a therapy that stimulates cellular repair. This is where PRP shines. A 2024 meta-analysis in AJSM concluded that, for lateral epicondylopathy, PRP provides better long-term outcomes for both functional improvement and pain relief compared with other treatments.

But just as with OA, dose is critical. A meta-regression analysis of PRP for tendinopathy found that high-dose PRP (greater than a threefold increase in platelet concentration) significantly outperformed controls, whereas low-dose PRP did not. The platelet concentration alone could explain 58% of the difference in outcomes.

The Integrative Chiropractic Approach: The Essential Foundation

While these advanced injectable therapies are powerful tools, they are most effective when integrated into a comprehensive treatment plan. As a Doctor of Chiropractic with advanced training in functional medicine and nursing, I always take a holistic approach. Lasting relief depends on addressing the root cause of the mechanical stress that led to the condition.

Integrative chiropractic care provides this essential foundation:

1. Biomechanical Assessment and Correction: Before any injection, a thorough biomechanical evaluation is critical. We must identify and correct any misalignments in the kinetic chain—from the foot and ankle, up through the hip and spine. An uncorrected gait abnormality or pelvic tilt will continue to place abnormal stress on the joint or tendon, undermining the benefits of any injection.
2. Manual Therapies: Chiropractic adjustments, soft tissue mobilization, and myofascial release techniques are used to restore proper joint mobility, reduce muscle tension, and improve nerve function. This not only alleviates pain but also creates an optimal mechanical environment for the joint to heal.
3. Therapeutic Exercise and Rehabilitation: A targeted exercise program is non-negotiable. Strengthening the muscles that support the affected area provides dynamic stability, reducing the load on the damaged tissue. Stretching improves flexibility and range of motion.
4. Functional Nutrition and Lifestyle: We address systemic inflammation through anti-inflammatory dietary strategies, targeted supplementation (e.g., omega-3 fatty acids, curcumin), and weight management. Reducing overall body weight has a profound effect on joint loading.

By combining cutting-edge injectable therapies like PRP with foundational integrative chiropractic care, we can offer patients a truly comprehensive and synergistic approach. We don’t just treat the pain; we address the inflammation, support tissue regeneration, and correct the underlying biomechanical and lifestyle factors to promote lasting health and an active, pain-free life.

References

• Altman, R., Hackel, J., Medina, R., & Revicki, D. (2016). Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis and Cartilage, 24(Suppl 1), S488.
• Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. R., Dragoo, J. L., & McCarty, E. C. (2023). Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. The American Journal of Sports Medicine, 51(13), 3613–3623.
• Farkas, G. J., Polgar, Z., Major, B., Hangody, L., & Vasarhelyi, G. (2024). High-Volume Single-Spin Leukocyte-Poor Platelet-Rich Plasma Injection Delays Total Knee Replacement in Kellgren-Lawrence Grade 3 and 4 Knee Osteoarthritis: A 10-Year Retrospective Follow-up Study. The American Journal of Sports Medicine, 52(1), 127–135.
• Kompel, A. J., Roemer, F. W., Murakami, A. M., Diaz, L. E., Crema, M. D., & Guermazi, A. (2019). Intra-articular Corticosteroid Injections in the Hip and Knee: Perhaps Not as Safe as We Thought? Radiology, 293(3), 656–663.
• McAlindon, T. E., LaValley, M. P., Harvey, W. F., Price, L. L., Driban, J. B., Zhang, M., & Ward, R. J. (2017). Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial. JAMA, 317(19), 1967–1975.
• Phillips, M., Bhandari, M., Grant, J., & Schemitsch, E. H. (2022). A systematic review of the evidence for viscosupplementation in inflammatory and non-inflammatory knee arthritis. JBJS reviews, 10(5).
• Saltychev, M., Harno, H., & Laimi, K. (2024). Effectiveness of intra-articular corticosteroid injections for knee osteoarthritis: an umbrella review of meta-analyses of randomized controlled trials. Rheumatology International, 44(5), 785–794.
• Saltzman, B. M., Cvetanovich, G. L., Nwachukwu, B. U., & Mather, R. C. (2022). The role of intra-articular ketorolac for the treatment of musculoskeletal conditions: a systematic review and meta-analysis. The Physician and Sportsmedicine, 50(1), 15–26.

SEO Tags: Osteoarthritis, Knee Pain, Tendinopathy, Dr. Alexander Jimenez, Corticosteroid Injections, Hyaluronic Acid, Viscosupplementation, Platelet-Rich Plasma, PRP, Ketorolac, Integrative Chiropractic, Functional Medicine, Joint Health, Regenerative Medicine, Chondrotoxicity, Knee Injection, Hip Pain, Non-Surgical Treatment, Biomechanics, El Paso Chiropractor, PRP dose, elbow pain, sports medicine, tendon healing, evidence-based medicine